AMERICAN CANCER SOCIETY INC (EIN 131788491) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1922

Legal Domicile

Phone

8002272345

Tax Period

2025-01-01 to 2025-03-31

AMERICAN CANCER SOCIETY INC, founded in 1922, is a major nonprofit in the Diseases & Disorders sector that reported $136.8M in total revenue in fiscal year 2024. Revenue fell 81% from the prior year — a significant decline worth monitoring. Expenses of $166.6M exceeded revenue, resulting in a 22% operating deficit.

Mission

IMPROVE THE LIVES OF PEOPLE WITH CANCER AND THEIR FAMILIES THROUGH ADVOCACY, RESEARCH, AND PATIENT SUPPORT, TO ENSURE EVERYONE HAS AN OPPORTUNITY TO PREVENT, DETECT, TREAT, AND SURVIVE CANCER.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $123,704,360

Program Service Revenue $157,034

Investment Income $15,092,907

Other Revenue $-2,127,953

TOTAL REVENUE $136,826,348

Expense Breakdown

Grants Paid $24,540,185

Salaries & Benefits $80,005,255

Fundraising Expenses $30,158,623

Program Expenses $128,365,470

Other Expenses $59,173,862

TOTAL EXPENSES $166,645,616

Year-over-Year Comparison

	2024	2023	Change
Revenue	$136,826,348	$724,184,531	-0.8%
Expenses	$166,645,616	$791,860,890	-0.8%
Net Income	$-29,819,268	$-67,676,359	-0.6%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

436638

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRIAN A MARLOW CFA	BOARD CHAIR	8.0	Officer Director	$0	$0	$0
CONNIE LINDSEY	BOARD SECRETARY	5.0	Officer Director	$0	$0	$0
KATHLEEN GALLAGHER MSN	BOARD TREASURER	5.0	Officer Director	$0	$0	$0
MARK A GOLDBERG MD	BOARD SCIENTIFIC OFFICER	5.0	Officer Director	$0	$0	$0
MICHAEL T MARQUARDT	BOARD IMMEDIATE PAST CHAIR	5.0	Officer Director	$0	$0	$0
TERRI MCCLEMENTS	BOARD VICE CHAIR	5.0	Officer Director	$0	$0	$0
ASIF DHAR MD MBA	BOARD DIRECTOR	3.0	Director	$0	$0	$0
DESIREE G ROGERS	BOARD DIRECTOR	3.0	Director	$0	$0	$0
EDISON T LIU MD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
JAIME WESOLOWSKI	BOARD DIRECTOR	3.0	Director	$0	$0	$0
JOSE C BUENAGA MBA	BOARD DIRECTOR	3.0	Director	$0	$0	$0
KAREN ETZKORN	BOARD DIRECTOR	3.0	Director	$0	$0	$0
KATIE A ECCLES ESQ	BOARD DIRECTOR	3.0	Director	$0	$0	$0
KENNETH R STOLL	BOARD DIRECTOR	3.0	Director	$0	$0	$0
MICHAEL PELLINI MD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
MICHELLE M LE BEAU PHD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
NORMAN E SHARPLESS MD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
ROBERT WINN MD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
SEAN T FARNHAM	BOARD DIRECTOR	3.0	Director	$0	$0	$0
KAEL REICIN	CHIEF FINANCIAL & STRATEGY OFFICER	55.0	Officer	$0	$0	$0
WAYNE A I FREDERICK MD MBA FACS	INTERIM CEO	55.0	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$136,826,348	$166,645,616	$1,652,874,190	$-29,819,268
2024	$724,184,531	$791,860,890	$1,746,878,475	$-67,676,359
2023	$656,838,115	$756,272,604	$1,809,676,040	$-99,434,489
2022	$674,472,929	$669,203,696	$1,780,605,245	$5,269,233
2021	$734,386,259	$577,661,256	$1,891,787,660	$156,725,003
2020	$576,295,531	$564,007,903	$1,700,046,787	$12,287,628
2019	$720,131,846	$730,686,668	$1,674,187,464	$-10,554,822
2018	$769,888,861	$740,575,770	$1,634,380,835	$29,313,091

AMERICAN CANCER SOCIETY INC